CDC?s Rigorous Attempts for Vaccination to Propel Growth of United States

Posted by Deeksha on January 22nd, 2019

Influenza infection affects millions of people every year, hundreds of thousands of people get hospitalized while tens of thousands succumb to the flu every year. Vaccination has been shown to have reduced hospitalizations, risk of flu illness and flu-related death in children. For the 2018-2019 influenza season, CDC advises use of age-appropriate and any licensed influenza vaccine along with recombinant influenza vaccine (RIV), inactivated influenza vaccine (IIV) or live attenuated influenza vaccine (LAIV).

These insights are according to the report titled, “United States Influenza Vaccines Market Report, Analysis and Forecast to 2025,” which has been lately incorporated in the exhaustive repository of Market Research Hub (MRH). According to a 2018 study of CDC, getting a flu shot decreased a pregnant woman’s risk of being hospitalized with flu by an average of 40 %, which has powered the United States influenza vaccines market.

According to CDC, during 2016-2017 influenza season, flu vaccination prevented almost 5.3 million influenza illnesses, 85,000 influenza-related hospitalizations and 2.6 million influenza-related medical visits. Further, a 2017 study revealed flu vaccination lessened intensive care unit (ICU) admissions, deaths, ICU length of stay and duration of hospitalization among flu patients. Given the prevalence of chronic diseases in the U.S., vaccination has been related to lowering rates of cardiac events and reducing hospitalization among people with chronic lung disease and diabetes. These factors have propelled the influenza vaccines market in the United States. 

United States Influenza Vaccines Market: Report Contents

The report provides a qualitative and quantitative analysis on the influenza vaccines market in the United States. The report further sheds light on the drivers, trends and inhibitors that have significant impact in the development of the United States influenza vaccines market. The report segregates the market to provide an in-depth view of the market.

Request for sample copy of this report@ https://www.marketresearchhub.com/enquiry.php?type=S&repid=1981195

The report starts with an exhaustive executive summary followed by market size and analysis for the period 2013-2025. The report further gives insights on distribution and demand of the effectiveness of influenza vaccines in the United States for the period 2004-2018. The report also gives granular assessment on the collaboration deal, merger & acquisitions, licensing agreement, distribution agreement and exclusive agreement in United States influenza vaccines market.

The final section of the report delineates the competitive landscape of the market with a dashboard view with analysis on company overview, financial overview, strategies, influenza vaccines portfolios, recent developments and sales value analysis. Some of the prominent players assessed in the report are, namely, GlaxoSmithKline (GSK), Sanofi Pasteur, Seqirus, Daiichi-Sankyo, Novavax and Mitsubishi TanabePharma.

Browse Full Report with TOC@@ https://www.marketresearchhub.com/report/united-states-influenza-vaccines-market-report-analysis-and-forecast-to-2025-report.html

United States Influenza Vaccines Market: Research Methodology

The research methodology in this report includes primary sources, secondary resources and assessment from expert panel for the forecast period 2018-2026. Primary sources encompass telephonic interviews, e-mail interactions and face to face interviews. Whereas, the secondary sources incorporate annual reports, national government documents, CDC, SEC filings, investors’ presentation, world bank database, internal and external proprietary database, market reports, industry white paper, regulatory database and statistical database. With the view to furnish readers with unbiased and authentic report, expert panel rigorously assesses the report.  The analysis of revenue forecast has been done on the basis of absolute dollar opportunity analysis.